Sawai Receives Approvals for Eight Generic Drugs with 20 Strengths
2021-02-15 · Upsher-Smith Laboratories · original upsher-smith.com ↗
Osaka, Japan – February 15, 2021 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) received approvals by the Ministry of Health, Labour and Welfare for eight generic drugs with 20 strengths. The five compounds marked with an asterisk below are approved for the first time as generics**. **Zilmlo® Combination Tablets, OD Tablets are Azilsartan and Amlodipine, and are counted as one compound. The list of approved products: 1. Eszopiclone Tablets Generic name: Eszopiclone* Strengths: 1mg, 2mg, 3mg Brand products: Lunesta® Tablets 1mg, 2mg, 3mg 2. Solifenacin Succinate Tablets, OD Tablets Generic name: Solifenacin Succinate* Strengths: Tablets, OD Tablets: 2.5mg, 5mg Brand products: Vesicare® Tablets 2.5mg, 5mg, Vesicare® OD Tablets 2.5mg, 5mg 3. Zilmlo® Combination Tablets, OD Tablets Generic name: Azilsartan・Amlodipine* Strengths: LD, HD Brand products: ZACRAS® Combination Tablets LD&HD 4. Epinastine Hydrochloride Ophthalmic Solution Generic name: Epinastine Hydrochloride Strengths: 0.05% Brand products: ALESION® Ophthalmic Solution 0.05% 5. Duloxetine Caplules Generic name: Duloxetine Hydrochloride* Strengths: 20mg, 30mg Brand products: Cymbalta® Capsules 20mg, 30mg 6. Tadalafil Tablets AD Generic name: Tadalafil Strengths: 20mg Brand products: Adcirca® Tablets 20mg 7. Pemetrexed for Intravenous Infusion, Intravenous Infusion Generic name: Pemetrexed Strengths: For Intravenous Infusion 800mg, Intravenous Infusion 100mg, 500mg, 800mg Brand products: Alimta® Injection 100mg, 500mg 8. Palonosetron Intravenous Infusion Bags Generic name: Palonosetron Hydrochloride* Strengths: 0.75mg/100mL Brand products: Aloxi® I.V. Infusion Bag 0.75mg The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States. ◆ Contact Information ◆ PR / IR Office, Sawai Pharmaceutical Co., Ltd. E-mail:[email protected]
The release as fetched from its publisher. upsher-smith.com ↗